08-123
Showing 1 - 25 of 2,874
Acne Vulgaris Trial in Canada, United States (IDP-123 Lotion, IDP-123 Vehicle Lotion)
Completed
- Acne Vulgaris
- IDP-123 Lotion
- IDP-123 Vehicle Lotion
-
Phoenix, Arizona
- +44 more
Mar 30, 2021
Acne Vulgaris Trial in Canada, United States (IDP-123 Lotion, IDP-123 Vehicle Lotion)
Completed
- Acne Vulgaris
- IDP-123 Lotion
- IDP-123 Vehicle Lotion
-
Mobile, Alabama
- +44 more
Mar 30, 2021
Acne Vulgaris Trial in United States (IDP-123 Lotion, Tazorac Cream, Vehicle Lotion)
Completed
- Acne Vulgaris
- IDP-123 Lotion
- +3 more
-
Encinitas, California
- +15 more
Sep 3, 2020
Healthy Adults Trial (Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L, DREP-HIV-PT1 1mg and CN54gp140/MPLA-L (see above), DNA-HIV-PT123
Not yet recruiting
- Healthy Adults
- Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L
- +2 more
- (no location specified)
Apr 9, 2021
IgA Nephropathy, Berger Disease Trial in Worldwide (Atacicept, Placebo to match Atacicept)
Active, not recruiting
- IgA Nephropathy
- Berger Disease
- Atacicept
- Placebo to match Atacicept
-
Tucson, Arizona
- +75 more
Jul 6, 2022
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)
Recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
-
Birmingham, Alabama
- +91 more
Jan 26, 2023
Patients Who Receive Colonoscopy Trial in Japan (NPF-08 (1-day treatment), NPF-08 (2-day split dose), Moviprep(1-day treatment))
Completed
- Patients Who Receive Colonoscopy
- NPF-08 (1-day treatment)
- +2 more
-
Abiko, Chiba, Japan
- +12 more
Nov 27, 2022
Systemic Lupus Erythematosus (SLE) Trial (Descartes-08)
Not yet recruiting
- Systemic Lupus Erythematosus (SLE)
- (no location specified)
Sep 8, 2023
Differentiated Thyroid Cancer Trial (Low iodine diet)
Not yet recruiting
- Differentiated Thyroid Cancer
- Low iodine diet
- (no location specified)
Oct 25, 2022
Lung Cancer Trial (TILT-123, Pembrolizumab)
Not yet recruiting
- Lung Cancer
- TILT-123
- Pembrolizumab
- (no location specified)
Nov 5, 2023
Parkinson Disease Trial in Paris (Identification of COMT HH, COMT HL or COMT LL genes, Brain MRI with resting state scan, Brain
Completed
- Parkinson Disease
- Identification of COMT HH, COMT HL or COMT LL genes
- +2 more
-
Paris, FranceGroupe Hospitalier Pitié-Salpêtrière
Feb 17, 2022
Solid Tumor, Adult Trial in Shanghai (3D011-08)
Recruiting
- Solid Tumor, Adult
-
Shanghai, Floor 2, Building 2, 270 Dong 'an Road, Xuhui District, ChinaFudan University Shanghai Cancer Center
Jan 2, 2023
Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)
Completed
- Bladder Cancer
- Metastatic Transitional Cell Carcinoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 16, 2021
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +6 more
-
Iowa City, Iowa
- +60 more
Jan 3, 2023
Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)
Recruiting
- Acute Myeloid Leukemia
- CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
-
Beijing, Beijing, China
- +2 more
Aug 8, 2023
Malignancy of Thyroid Nodules Trial in France (MIBI-Tc99m/Iodine-123)
Unknown status
- Malignancy of Thyroid Nodules
-
Angers, France
- +6 more
Feb 8, 2021
MDD (MDD) Trial (Aripiprazole, Escitalopram)
Terminated
- Major Depressive Disorder (MDD)
- (no location specified)
Nov 24, 2021
Bacterial Ecology of Pilonidal Cysts
Recruiting
- Pilonidal Cysts
-
Lyon, FranceClinique de la Sauvegarde
Aug 23, 2022
Chemo-induced Peripheral Neuropathy Trial in Japan, United States (thrombomodulin alfa, Placebo)
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
- thrombomodulin alfa
- Placebo
-
Beverly Hills, California
- +14 more
May 26, 2022
Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)
Recruiting
- Platinum-refractory Ovarian Carcinoma
- Platinum-resistant Ovarian Cancer
- TILT-123
- Pembrolizumab
-
Rochester, Minnesota
- +1 more
Aug 12, 2022
Pulmonary Arterial Hypertension Trial (MN-08 24 mg/day, MN-08 60 mg/day)
Not yet recruiting
- Pulmonary Arterial Hypertension
- MN-08 24 mg/day
- MN-08 60 mg/day
- (no location specified)
Dec 14, 2022